Picture of Praxis Precision Medicines logo

PRAX — Praxis Precision Medicines News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapMomentum Trap

Independent committee says Praxis' tremor drug trial unlikely to meet main goal

Feb 28 (Reuters) - Praxis Precision Medicines PRAX.O said on Friday an independent committee had recommended its tremor drug trial be stopped for futility, as it was unlikely to meet its main goal.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shreya Biswas)

 ((Sriparna.Roy@thomsonreuters.com;))

Recent news on Praxis Precision Medicines

See all news